Navigation Links
NASDAQ in Medical News

XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution

MENLO PARK, Calif., Aug. 5 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that it has provided written notice to The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. The Company currently ...

Mylan Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Closing Bell

PITTSBURGH, July 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its Chairman and CEO Robert J. Coury will preside over the NASDAQ Stock Market closing on Thursday, July 30 from 3:45 to 4:00 p.m. ET. Feed Information: The Closing Bell is available from ...

eDiets.com(R) Receives NASDAQ Notice of Non-Compliance

FORT LAUDERDALE, Fla., July 9 /PRNewswire-FirstCall/ --eDiets.com, Inc. (Nasdaq: DIET ) , a leading provider of convenient at-home diet, fitness and healthy lifestyle solutions, today announced that, on July 2, 2009, the Company received a NASDAQ Staff Determination indicating that t...

Biopure Receives Notice of Nasdaq Delisting

CAMBRIDGE, Mass., June 30 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR ) announced that it has received notice from The Nasdaq Stock Market, by letter dated June 24, 2009, that it is out of compliance with the Nasdaq Marketplace Rules and its common stock may be delisted. The no...

ERT Officials Ring the NASDAQ Closing Bell

PHILADELPHIA , June 18 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES ), a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, closed the stock market on 18 June by ringing the famous NASDAQ bell. ...

Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements

NEW YORK, June 17 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) announced today that the Company has received a letter from The NASDAQ Stock Market confirming that it has regained compliance with the minimum bid price requirement for continued listing on The NASDAQ Cap...

Endologix Receives Nasdaq Letter on Director Independence

IRVINE, Calif. , June 12 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, today announced that on June 12, 2009, the Company received written notification from Nasdaq that the Company was no longer in compliance with Mar...

Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance

NEW YORK, June 9 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced that on June 5, 2009, it received a letter from the NASDAQ Listing Qualifications Hearings Panel granting the Company an extension through August 31, 2009, to regain compliance with Nasdaq L...

DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares

Company to trade in the Over-the-Counter Market CLEVELAND, June 4 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: DATA ), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it received notification o...

The Female Health Company Switches to the NASDAQ Stock Market

CHICAGO, May 29 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Amex: FHC ) announced today that its Board of Directors has approved the decision to switch the listing of its common stock from the NYSE AMEX LLC to the NASDAQ Stock Market LLC. Effective as of the opening of trading on T...
NASDAQ in Medical Technology

Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity

... within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the nasdaq Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com . ...

New Review on PROSTVAC(TM) Published by Key Investigators From NCI

...nt for the late-stage development and procurement of the company's third-generation smallpox vaccine, IMVAMUNE(R). Bavarian Nordic is listed on nasdaq OMX Copenhagen under the symbol BAVA. For more information please visit http://www.bavarian-nordic.com ...

Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications

...ris Pharmaceuticals, Alnylam, Repligen Corporation, Alkermes, Inc., Momenta Pharmaceuticals and Cubist Pharmaceuticals, which were taken public on the nasdaq and are well established as companies that develop and market new medicines. "This is an exciting time to launch a biotechnology endeavor in Hong Kon...

Spherix Announces Positive Phase 2 Study Results

...ry may experience negative market trends, our continuing efforts to develop Naturlose may be unsuccessful, our common stock could be delisted from the nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our current report ...

DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey

... Founded in 1979, TechTeam has nearly 3,000 employees across the world, providing IT support in 32 languages. TechTeam's common stock is traded on the nasdaq Global Market under the symbol "TEAM." For more information, call 800-522-4451 or visit www.techteam.com . Contacts: TechTeam Global...

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction

...ellectual property, our ability to continue to list our common stock on the nasdaq Global Market or to list our common stock on the nasdaq Capital Market and those other factors described in the Company's Annual Re...

Invitation: PROSTVAC(TM) Wrap up

...dical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases. Bavarian Nordic is listed on nasdaq OMX Copenhagen under the symbol BAVA. For more information please visit http://www.bavarian-nordic.com ...

Spherix Reports First Quarter 2009 Earnings

...ry may experience negative market trends, our continuing efforts to develop Naturlose may be unsuccessful, our common stock could be delisted from the nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our current report ...

Spherix Elects New Independent Director, and Elects Chairman of the Board

...With the election of Mr. Peter to Spherix's Board, the Company has notified nasdaq that it has regained compliance with NASDAQ's rule that requires a majority... Naturlose may be unsuccessful, our common stock could be delisted from the nasdaq Capital Market, and other risks and challenges detailed in our filings with...

Bionovo Announces First Quarter 2009 Highlights and Financial Results

... within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the nasdaq Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com . Forward Look...
NASDAQ in Biological News

VUANCE Announces Crime Scene Security and Evidentiary Tracking Development Project

...d other public initiatives. VUANCE is serious about security. VUANCE Ltd. is headquartered in Rockville, MD. Its common stock is listed on the nasdaq Capital Market under the symbol "VUNC". For more information, visit http://www.vuance.com . Safe Harbor This press release contains f...

Court Approves Scheme of Arrangement

...e Limited's ADSs on a one-for-one basis, each Shire Limited ADS representing three ordinary shares in Shire Limited. Dealings in Shire Limited ADSs on nasdaq will commence at 9:30 a.m. (EST) on 23 May 2008. Immediately prior to the scheme becoming effective, Shire Limited will be substituted in place of S...

Sonic Innovations Celebrates 10-Year Anniversary

...ically proven to increase speech understanding in noise for the hearing impaired. Sonic Innovations, headquartered in Salt Lake City, is listed on the nasdaq Global Market System and can be found online at http://www.sonici.com . This press release may contain "forward-looking statements" as defined unde...
NASDAQ in Biological Technology

Sunesis Receives Approval for Listing on The NASDAQ Capital Market

SOUTH SAN FRANCISCO, Calif., July 30 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced th...

Anesiva Receives NASDAQ Delisting Staff Determination Letter

SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) received, as previously disclosed on its Current Report on Form 8-K filed with the Securities and Exchange Commission on April 2, 2009 and in its press release on April 1, 2009, a letter from t...

TorreyPines Receives Notice of Delisting from Nasdaq Global Market

LA JOLLA, Calif., July 20 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) announced today that it had received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market notifying the Company that it did not comply with the minimum $10,000,000 stockholders...

deCODE Reinstated to Nasdaq Global Market

REYKJAVIK, Iceland, June 26 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN ) today announced that it has received notice from the the Nasdaq Hearing and Listing Review Council that the listing of the company's common stock will be reinstated to the Nasdaq Global Market effective from...

Spherix Regains Full NASDAQ Compliance

BETHESDA, Md., May 22 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for diabetes therapy and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has ful...

Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice

CORAL GABLES, Fla., May 22 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today announced that on May 19, 2009 it was advised by The NASDAQ Stock Market(R) that, based on the Company's stockholders equity as reported in the Company's Quarterly Report on Form 10-...

Insmed Regains NASDAQ Compliance

RICHMOND, Va., May 5 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market that it has regained compliance with the minimum $1.00 per share bid price requirement, and further, that it c...

AEterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

QUEBEC CITY, April 29 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced it has received notification from the Nasdaq Stock Market ("Nasdaq") that it has regained compliance with ...

Spherix Recruiting New 'Independent' Director to Regain NASDAQ Compliance

BETHESDA, Md., April 27 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that on Apri...

Sunesis Pharmaceuticals Receives NASDAQ Notification

SOUTH SAN FRANCISCO, Calif., April 17 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) reported today that it received a letter, dated April 14, 2009, from the Listing Qualifications Department of The NASDAQ Stock Market notifying the Company that it does not comply with t...
Other Tags
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... Scientists have identified the first genetic variant specifically ... sub-type accounting for around 10-15 per cent of ... study of the breast cancer sub-type, called invasive ... genetic causes of this particular kind of breast ... The research, published today (Thursday) in the journal ...
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... 2014) Two recent papers by a University ... may help scientists develop treatments or vaccines for ... encephalitis and other disease-causing flaviviruses. , Jeffrey S. ... genetics at the School of Medicine and an ... Institute, and colleagues recently published articles in the ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
(Date:4/18/2014)... For the past 20 years, researchers have published soil ... findings have suggested that soil organic carbon can be ... systems to no-till systems. However, there is a growing ... corn and soybean rotations without cover crops, small grains, ... stocks at the published rates. , "Some studies have ...
(Date:4/18/2014)... Asteroid and comet impacts can cause widespread ecological havoc, ... global scales. But new research from Brown University shows ... life at the time of an impact. , A ... found fragments of leaves and preserved organic compounds lodged ... Argentina. The material could provide a snapshot of environmental ...
(Date:4/17/2014)... A drug under clinical trials to treat tuberculosis ... drugs that act against various bacteria, fungal infections and ... University of Illinois chemists and collaborators. , Led by ... determined the different ways the drug SQ109 attacks the ... target other pathogens from yeast to malaria and ...
Breaking Biology News(10 mins):Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Impact glass stores biodata for millions of years 2Impact glass stores biodata for millions of years 3Multitarget TB drug could treat other diseases, evade resistance 2
Other Contents